The State Health Department Secretary publicly announced on Thursday that patients diagnosed with anxiety disorders and/or Tourette’s syndrome will be eligible to receive recommendations to legally access medical cannabis products. The new rules take effect on July 20.

Lieutenant Gov. John Fetterman called the changes “a truly powerful expansion” of the state’s program.

An estimated 110,000 patients and over 1,600 physicians currently participate in the state-sponsored access program.